AQR Capital Management »

Rocket Pharmaceuticals shares owned by AQR Capital Management

Quarter-by-quarter ownership of Rocket Pharmaceuticals (RCKT) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Rocket Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rocket Pharmaceuticals held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rocket Pharmaceuticals by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $349k 19k 18.47
2024-03-31 $273k 10k 27.00
2023-12-31 $242k 8.1k 29.97

More positions owned by AQR Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Ge Aerospace Com New (GE)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Johnson & Johnson (JNJ)
Zoom Video Communications In Cl A (ZM)
Cigna Corp (CI)
At&t (T)
Progressive Corporation (PGR)
Alphabet Cap Stk Cl C (GOOG)

View all positions for AQR Capital Management

Top funds holding Rocket Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
Westfield Capital Management Company
Maverick Capital
T. Rowe Price Associates
Henderson Group
State Street Corporation
Citadel Advisors
Franklin Resources
Geode Capital Management
Frazier Life Sciences Management
Boxer Capital
Pictet Asset Management Holding SA
Novo A/S

View all funds holding Rocket Pharmaceuticals